Find link

language:

jump to random article

Find link is a tool written by Edward Betts.

searching for Hsp90 inhibitor 14 found (19 total)

alternate case: hsp90 inhibitor

Chaperome (733 words) [view diff] exact match in snippet view article find links to article

adapting to stress including hypoxia and heat. The small molecule Hsp90 inhibitor, PU-H71, has been found to have a preferential binding to Hsp90 when
Radicicol (269 words) [view diff] case mismatch in snippet view article find links to article
"Functional Characterization of the Biosynthesis of Radicicol, an Hsp90 Inhibitor Resorcylic Acid Lactone from Chaetomium chiversii". Chemistry & Biology
LYN (3,807 words) [view diff] case mismatch in snippet view article find links to article
rheostat that modulates signaling rather than as a binary on-off switch. HSP90 inhibitor NVP-BEP800 has been described to affect stability of LYN kinase and
Proto-oncogene tyrosine-protein kinase Src (2,794 words) [view diff] case mismatch in snippet view article find links to article
trials include bosutinib, bafetinib, AZD-0530, XLl-999, KX01 and XL228. HSP90 inhibitor NVP-BEP800 has been described to affect stability of Src tyrosine kinase
Paul Workman (scientist) (955 words) [view diff] exact match in snippet view article
cells, in particular, molecular chaperones such as Hsp90. The leading Hsp90 inhibitor was discovered by Workman's team at ICR in collaboration with Vernalis
Vernalis Research (1,160 words) [view diff] exact match in snippet view article find links to article
July 2015. Additionally, luminespib (AUY922) is a novel intravenous Hsp90 inhibitor with the potential to target a range of cancers, which arose from a
Lck (4,453 words) [view diff] case mismatch in snippet view article find links to article
have some impact on its therapeutic effects in canine mastocytoma. HSP90 inhibitor NVP-BEP800 has been described to affect stability of the LCK kinase
FNIP1 (707 words) [view diff] exact match in snippet view article find links to article
Trepel JB, Whitesell L, Picard D (July 2018). "Methods to validate Hsp90 inhibitor specificity, to identify off-target effects, and to rethink approaches
Clusterin (2,433 words) [view diff] no match in snippet view article find links to article
that blocks the CLU mRNA transcript, enhanced heat-shock protein 90 (HSP90) inhibitor activity by suppressing the heat-shock response in castrate-resistant
Lutetium (177Lu) chloride (678 words) [view diff] case mismatch in snippet view article
Lundsten S, Spiegelberg D, Stenerlöw B, Nestor M (December 2019). "The HSP90 inhibitor onalespib potentiates 177Lu‑DOTATATE therapy in neuroendocrine tumor
List of pharmaceutical compound number prefixes (1,656 words) [view diff] case mismatch in snippet view article find links to article
Archived from the original on 2012-04-16. Retrieved 2012-04-17. "Exelixis HSP90 inhibitor XL888". Archived from the original on 2016-09-18. Retrieved 2016-09-16
Heat shock protein (5,525 words) [view diff] exact match in snippet view article find links to article
HSPs, especially Hsp90 show promise as anticancer agents. The potent Hsp90 inhibitor 17-AAG was in clinical trials for the treatment of several types of
Hsp70 (5,631 words) [view diff] exact match in snippet view article find links to article
et al. (June 2018). "Targeted cancer therapy through 17-DMAG as an Hsp90 inhibitor: Overview and current state of the art". Biomedicine & Pharmacotherapy
Heat shock protein 90kDa alpha (cytosolic), member A1 (8,175 words) [view diff] exact match in snippet view article
most amenable to inhibitor generation. To date, there are 23 active Hsp90 inhibitor oncology trials, and 13 HSP90 inhibitors are currently undergoing clinical